Target Name: IL17RE
NCBI ID: G132014
Review Report on IL17RE Target / Biomarker Content of Review Report on IL17RE Target / Biomarker
IL17RE
Other Name(s): FLJ23658 | MGC71884 | Interleukin-17 receptor E | IL-17 receptor E | IL17RE variant 1 | Interleukin 17 receptor E | Interleukin 17 receptor E, transcript variant 1 | IL-17RE | Interleukin-17 receptor E (isoform 1) | interleukin 17 receptor E | I17RE_HUMAN

IL17RE: A Protein Involved in Various Cellular Processes and Disease Development

IL17RE (interleukin-17 receptor) is a protein that is expressed in various tissues throughout the body, including the immune system, endothelial cells, and epithelial cells. It is a member of the IL17 receptor family, which is a subclass of the IL-17 receptor family that is involved in the regulation of immune and inflammatory responses.

IL17RE is involved in the regulation of various cellular processes in the body, including cell signaling, cell adhesion, and cytokine production. It has been shown to play a role in the development and progression of various diseases, including cancer, autoimmune diseases, and chronic obstructive pulmonary disease (COPD).

One of the key functions of IL17RE is its role in the regulation of immune responses. IL17RE has been shown to promote the recruitment and activation of immune cells, including T cells and NK cells, which are important for the regulation of immune responses against infections and cancer.

In addition to its role in immune regulation, IL17RE is also involved in the regulation of cell signaling and cell adhesion. It has been shown to play a role in the regulation of cell proliferation, cell differentiation, and cell-cell adhesion.

IL17RE has also been shown to be involved in the regulation of cytokine production and cell signaling. It has been shown to promote the production of pro-inflammatory cytokines, such as IL-1尾 and IL-6, and to regulate the activity of immune cells, including T cells and NK cells.

In addition to its role in immune and inflammatory regulation, IL17RE is also involved in the regulation of various cellular processes in the body, including cell signaling, cell adhesion, and cytokine production. It has been shown to play a role in the development and progression of various diseases, including cancer, autoimmune diseases, and COPD.

Despite the potential importance of IL17RE as a drug target or biomarker, further research is needed to fully understand its role in the regulation of cellular processes in the body.

In conclusion, IL17RE is a protein that is expressed in various tissues throughout the body that is involved in the regulation of various cellular processes in the body. It is a member of the IL17 receptor family and has been shown to play a role in the development and progression of various diseases, including cancer, autoimmune diseases, and COPD. Further research is needed to fully understand its role in the regulation of cellular processes in the body.

Protein Name: Interleukin 17 Receptor E

Functions: Specific functional receptor for IL17C. May be signaling through the NF-kappa-B and MAPK pathways. May require TRAF3IP2 /ACT1 for signaling. May be a crucial regulator in innate immunity to bacterial pathogens. Isoform 2 and isoform 4 may be either cytoplasmic inactive or dominant active forms. Isoform 3 and isoform 5 may act as soluble decoy receptors

The "IL17RE Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL17RE comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

IL17REL | IL18 | IL18BP | IL18R1 | IL18RAP | IL19 | IL1A | IL1B | IL1F10 | IL1R1 | IL1R2 | IL1RAP | IL1RAPL1 | IL1RAPL2 | IL1RL1 | IL1RL2 | IL1RN | IL2 | IL20 | IL20RA | IL20RB | IL21 | IL21-AS1 | IL21R | IL21R-AS1 | IL22 | IL22RA1 | IL22RA2 | IL23A | IL23R | IL24 | IL25 | IL26 | IL27 | IL27RA | IL2RA | IL2RB | IL2RG | IL3 | IL31 | IL31RA | IL32 | IL33 | IL34 | IL36A | IL36B | IL36G | IL36RN | IL37 | IL3RA | IL4 | IL4I1 | IL4R | IL5 | IL5RA | IL6 | IL6-AS1 | IL6R | IL6R-AS1 | IL6ST | IL6ST-DT | IL6STP1 | IL7 | IL7R | IL9 | IL9R | IL9RP3 | IL9RP4 | ILDR1 | ILDR2 | ILF2 | ILF3 | ILF3-DT | ILK | ILKAP | ILRUN | ILVBL | Imidazoline I2 receptor (I2) | Imidazoline I3 receptor (I3) | Imidazoline receptor | IMMP1L | IMMP2L | IMMT | IMMTP1 | Immunoglobulin A | Immunoglobulin E (IgE) | Immunoglobulin G | Immunoglobulin M | Immunoglobulin-Like Domain Containing Receptor | Immunoproteasome | IMP3 | IMP4 | IMPA1 | IMPA1P1 | IMPA2 | IMPACT | IMPDH1 | IMPDH1P10 | IMPDH1P6 | IMPDH2